Novo Nordisk secures FDA approval for groundbreaking GLP-1 obesity pill, leaving Eli Lilly scrambling to catch up. What does this mean for the future of weight loss treatments?
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
8 min read
Continue reading in the USA News Updates app